75 related articles for article (PubMed ID: 604137)
1. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.
Kuwert EK; Höher PG; Werner J; Scheiermann N; Thraenhart O; Müller B; Kleber G
Dev Biol Stand; 1977 Jun 1-3; 39():77-83. PubMed ID: 604137
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials with a new influenza subunit vaccine in adults and children.
Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
[TBL] [Abstract][Full Text] [Related]
3. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
Muhamed G; Greenbaum E; Zakay-Rones Z
Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
8. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
9. Modulation of humoral immune response to influenza vaccines by BCG.
Zykov MP; Subbotina TI
Acta Virol; 1985 Sep; 29(5):403-9. PubMed ID: 2866694
[TBL] [Abstract][Full Text] [Related]
10. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza I. Hemagglutinationinhibiting antibodies (author's transl)].
Kuwert EK; Werner J; Scheiermann N; Pledt T
Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):155-74. PubMed ID: 506543
[TBL] [Abstract][Full Text] [Related]
11. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
[TBL] [Abstract][Full Text] [Related]
12. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses.
Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M
Dev Biol Stand; 1977 Jun 1-3; 39():231-4. PubMed ID: 604101
[TBL] [Abstract][Full Text] [Related]
13. Dynamics and specificity of influenza virus antibodies as well as IgE values in serum and nasal fluid after repeated local application of live bivalent influenza vaccine.
Werner J; Kuwert EK
Dev Biol Stand; 1977 Jun 1-3; 39():135-40. PubMed ID: 604096
[TBL] [Abstract][Full Text] [Related]
14. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers.
Alekseeva AK; Andzhaparidze OG; Gracheva EN; Sidorova LA; Melnikova SK
Acta Virol; 1979 Jan; 23(1):59-66. PubMed ID: 35960
[TBL] [Abstract][Full Text] [Related]
15. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
Schmidt S; Süss J; Oehring H; Schmidt J
Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults.
Ben-Yehuda A; Joseph A; Zeira E; Even-Chen S; Louria-Hayon I; Babai I; Zakay-Rones Z; Greenbaum E; Barenholz Y; Kedar E
J Med Virol; 2003 Apr; 69(4):560-7. PubMed ID: 12601765
[TBL] [Abstract][Full Text] [Related]
17. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
Gorse GJ; O'Connor TZ; Newman FK; Mandava MD; Mendelman PM; Wittes J; Peduzzi PN
J Infect Dis; 2004 Jul; 190(1):11-9. PubMed ID: 15195238
[TBL] [Abstract][Full Text] [Related]
18. The use of live attenuated influenza vaccine ts-1(E) in man.
Gwaltney JM
Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
20. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
Dolezalová B; Závadová H; Stárek M; Vonka V
Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
